Ma-Xing-Shi-Gan decoction alleviates allergic asthma by modulating the gut microbiota—tryptophan metabolism—ILC2 axis
Phytomedicine · 2026-08 · 158 · 158378
DOI: 10.1016/j.phymed.2026.158378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-08. Verfasst von Mengmeng Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102401, PR China. Hauptthemen laut MEDLINE: Asthma, Tryptophan, Drugs, Chinese Herbal, Gastrointestinal Microbiome. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing University of Chinese Medicine, Beijing Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Ma-Xing-Shi-Gan decoction (MXSG) shows clinical efficacy in asthma, yet how it shapes gut-lung immunity-particularly type 2 innate lymphoid responses-remains poorly defined. PURPOSE: To investigate whether MXSG mitigates asthma by restraining group 2 innate lymphoid cells (ILC2s) via a gut microbiota-tryptophan metabolic pathway, and to identify microbiota-dependent active compounds. METHODS: An asthma mouse model was used. ILC2 in the lung and intestinal lamina propria were assessed by flow cytometry. Rag1⁻/⁻ mice were used to assess T and B cell-independent effects. Untargeted fecal metabolomics and antibiotic-mediated microbiota depletion were conducted to evaluate metabolic and microbial contributions. Microbiota-dependent MXSG constituents were traced using anaerobic fecal fermentation coupled with LC-MS/MS profiling, followed by in vivo validation. RESULTS: MXSG significantly alleviated pulmonary inflammation, reduced bronchoalveolar lavage eosinophils and improved histopathology. It decreased ILC2s populations in lung and gut. These effects were preserved in Rag1⁻/⁻ mice but abolished with antibiotics pretreatment, indicating microbiota dependence. Metabolomics revealed that MXSG reprogrammed tryptophan metabolism, restoring tryptamine and rebalancing kynurenine, indole, and serotonin-related branches. Anaerobic fermentation and LC-MS/MS profiling identified microbiota-dependent flavonoids, and isorhamnetin partially reproduced the anti-inflammatory and ILC2-modulating effects in vivo. CONCLUSION: MXSG exerts its anti-asthmatic effects via the gut microbiota-tryptophan metabolism-ILC2 axis. These findings reveal a novel gut-lung mechanism centered on type 2 innate immunity and microbiota-derived indole metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102401, PR China.
- Zhongshan People's Hospital, Zhongshan 528429, PR China.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102401, PR China.
- School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102401, PR China. Electronic address: penggy@bucm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Beijing University of Chinese Medicine
- Beijing Natural Science Foundation
Zitieren
APA
Lv, M., Wang, C., Hong, Y., Ye, F., Cao, X., Zheng, Z., Zhang, E., Liu, J., Jia, A., & Peng, G. (2026). Ma-Xing-Shi-Gan decoction alleviates allergic asthma by modulating the gut microbiota—tryptophan metabolism—ILC2 axis. Phytomedicine, 158, 158378. https://doi.org/10.1016/j.phymed.2026.158378
Vancouver
Lv M, Wang C, Hong Y, Ye F, Cao X, Zheng Z, et al. Ma-Xing-Shi-Gan decoction alleviates allergic asthma by modulating the gut microbiota—tryptophan metabolism—ILC2 axis. Phytomedicine. 2026;158:158378. doi:10.1016/j.phymed.2026.158378
BibTeX
@article{Lv2026,
author = {Lv, Mengmeng and Wang, Chen and Hong, Yanfei and Ye, Fei and Cao, Xiaoyu and Zheng, Zhixin and Zhang, Enning and Liu, Jie and Jia, Anqi and Peng, Guiying},
title = {Ma-Xing-Shi-Gan decoction alleviates allergic asthma by modulating the gut microbiota—tryptophan metabolism—ILC2 axis},
journal = {Phytomedicine},
year = {2026},
volume = {158},
pages = {158378},
doi = {10.1016/j.phymed.2026.158378}
}
EUVIMED